共 8 条
[1]
[2]
[3]
[4]
[5]
New therapeutic perspectives in CCDC 6 deficient lung cancer cells[J] Francesco Morra;Chiara Luise;Roberta Visconti;Stefania Staibano;Francesco Merolla;Gennaro Ilardi;Gianluca Guggino;Simona Paladino;Daniela Sarnataro;Renato Franco;Roberto Monaco;Federica Zitomarino;Roberto Pacelli;Guglielmo Monaco;Gaetano Rocco;Aniello Cerrato;Spiros Linardopoulos;Mark T. Muller;Angela Celetti Int. J. Cancer 2015,
[6]
CCDC134 is down-regulated in gastric cancer and its silencing promotes cell migration and invasion of GES-1 and AGS cells via the MAPK pathway[J] Jialing Zhong;Mei Zhao;Qing Luo;Yiming Ma;Jian Liu;Jia Wang;Mei Yang;Xinghua Yuan;Jianli Sang;Changzhi Huang Molecular and Cellular Biochemistry 2013,
[7]
Isolation of siRNA target by biotinylated siRNA reveals that human CCDC12 promotes early erythroid differentiation[J] Cuiqing Fan;Lin Dong;Ning Zhu;Yuan Xiong;Jiewen Zhang;Le Wang;Yan Shen;Xiaoyin Zhang;Meihong Chen Leukemia Research 2011,
[8]
PI3K/Akt/mTOR Pathway Inhibitors in Cancer:A Perspective on Clini-cal Progress P Wu;YZ Hu; Current Medicinal Chemistry 2010,

